All Stories

  1. A modified COMSA score is a good tool to identify responders and non-responders to mepolizumab in severe asthma

    Article • September 2023, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  2. Late Breaking Abstract - Dynamics of the blood innate lymphoid cell compartment in patients with severe asthma undergoing type 2 biologics treatment: Initial findings in the BIOCROSS study

    Article • September 2023, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  3. Severe asthma trajectories in adults: findings from the NORDSTAR cohort

    Article • European Respiratory Journal, August 2023, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  4. Low levels of endogenous anabolic androgenic steroids in females with severe asthma taking corticosteroids

    Article • ERJ Open Research, August 2023, European Respiratory Society (ERS)

    Lars I. Andersson, Dr Valentyna Yasinska

  5. Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort

    Article • ERJ Open Research, February 2023, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  6. Definitions of non-response and response to biological therapy for severe asthma: a systematic review

    Article • ERJ Open Research, January 2023, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  7. Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)

    Article • European Respiratory Journal, October 2022, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  8. The prevalence of severe asthma, use of oral corticosteroid and management strategies in the Nordic countries: results from the pan-Nordic NORDSTAR cohort

    Article • September 2022, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  9. Eosinophilic airway diseases: basic science, clinical manifestations and future challenges

    Article • European Clinical Respiratory Journal, March 2022, Taylor & Francis

    Dr Valentyna Yasinska

  10. Mepolizumab decreases urinary excretion of LTE4 in severe asthma

    Article • September 2020, European Respiratory Society (ERS)

    Dr Valentyna Yasinska

  11. NORDSTAR – Paving the way for a new era in asthma research

    Article • European Respiratory Journal, March 2020, European Respiratory Society (ERS)

    Kirk Geale, Dr Valentyna Yasinska

  12. Severe asthma in different European registries

    Article • European Respiratory Journal, October 2019, European Respiratory Society (ERS)

    Job J.M.H. van Bragt, Dr Valentyna Yasinska